Home > Press > Fully automated DNA lab-on-a-chip microfluidic system wins Dolomite’s Productizing Science® competition 2013
Abstract:
Dolomite have announced the winner of their 2013 Productizing Science® competition as Molbot Pte. Ltd. The company submitted the concept of a low-cost bench-top molecular biology "Minilab" for automating molecular biology applications.
Dolomite's Productizing Science® Competition seeks to find innovative microfluidic concepts and give the winner the chance to develop theirs into a commercially successful product and share in the rewards. Molbot's molecular biology workstation Minilab will utilize microfluidic technology to take traditional sequential manipulations such as PCR assembly, thermal cycling, analysis and purification and perform them ‘on chip' in an automated way. The concept is to integrate traditional ‘stand-alone' systems such as imaging, PCR, centrifuge, electrophoresis and pipetting and combine them into one automated system.
The product will be the machine, which will be used with disposable labs-on-chips, different types of which will represent different applications and will be automatically identified by the machine. Users will load the microfluidic chip and necessary reagents in the machine and the Minilab will execute the required functions for the task, meaning that user input is kept to an absolute minimum. The main appeal of the Minilab is that it will be considerably cheaper than existing technology-driven specialist microfluidic products. Focused more on user needs, it will be a product that is useful and attainable for many biology laboratories.
Dolomite were impressed with Molbot's user-friendly and user-focused concept and saw the benefits it would provide to a number of applications such as DNA testing, genotyping, DNA purification and especially plasmid DNA cloning. The latter involves stitching two pieces of DNA strands together to make a new gene combination, which is an important, time- consuming and often failure-prone task. The automated nature of the Minilab minimises the need for user interaction, which not only saves time but also reduces the risk of failure.
Working with Molbot, Dolomite's engineering expertise and knowledge and understanding of microfluidic droplet technologies will take their winning concept into a productized commercial solution which will be available to buy from Dolomite's microfluidic webshop.
Notable runner-ups were Amar Basu of Wayne State University, US, who came up with a software/hardware solution for measuring and controlling droplet size in real time and also Michele Zagnoni, of the University of Strathclyde, UK, who designed a reusable and semi- automated microfluidic architecture for ion channel drug screening. While the Productizing Science® competition can only have one winner, both runner-ups had concepts worthy of future discussion with Dolomite.
####
About The Dolomite Centre Limited
Established in 2005 as the world’s first Microfluidic Application Centre, Dolomite focused on working with customers to turn their concepts for microfluidic applications into reality. Today, Dolomite is the world leader in solving microfluidic problems. With offices in the UK and US and distributors throughout the rest of the world, its clients range from universities developing leading-edge analytical equipment, to manufacturers of chemical, life sciences and clinical diagnostics systems.
Dolomite is pioneering the use of microfluidic devices for small-scale fluid control and analysis, enabling manufacturers to develop more compact, cost-effective and powerful instruments. By combining specialist glass, quartz and ceramic technologies with knowledge of high performance microfluidics, Dolomite is able to provide solutions for a broad range of application areas including environmental monitoring, clinical diagnostics, food and beverage, nuclear, agriculture, petrochemical, cosmetics, pharmaceuticals and chemicals. Furthermore Dolomite's in-house micro-fabrication facilities that include clean rooms and precision glass processing facilities allow to prototype and test all solutions rapidly which ensures a faster development cycle and reduces the time to market.
For more information, please click here
Contacts:
The Dolomite Centre Ltd
1 Anglian Business Park, Orchard Road, Royston, Hertfordshire, SG8 5TW, UK
T: +44 (0)1763 242491
F: +44 (0)1763 246125
Copyright © The Dolomite Centre Limited
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Microfluidics/Nanofluidics
Implantable device shrinks pancreatic tumors: Taming pancreatic cancer with intratumoral immunotherapy April 14th, 2023
Researchers design new inks for 3D-printable wearable bioelectronics: Potential uses include printing electronic tattoos for medical tracking applications August 19th, 2022
Oregon State University research pushes closer to new therapy for pancreatic cancer May 6th, 2022
Lab-on-a-chip
Micro-scale opto-thermo-mechanical actuation in the dry adhesive regime Peer-Reviewed Publication September 24th, 2021
Silicon-graphene hybrid plasmonic waveguide photodetectors beyond 1.55 μm March 13th, 2020
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Atomic force microscopy in 3D July 5th, 2024
Aston University researcher receives £1 million grant to revolutionize miniature optical devices May 17th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||